On August 26, 2023, the Board of Directors of Omega Therapeutics, Inc. elected Michelle C. Werner as a Class I director of the Company and appointed Ms. Werner as a member of the Board?s Nominating and Corporate Governance Committee, effective August 28, 2023. On the Effective Date, Noubar B. Afeyan, Ph.D., submitted his resignation as a member of and Chair of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -0.94% | -3.65% | -29.90% |
05-06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.90% | 117M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Omega Therapeutics, Inc. Announces Board Changes